Although longer-term studies are necessary to better assess the potential impact on motor neuron survival, this study indicates that activin inhibition is an effective therapeutic strategy to enhance muscle function in a mouse model of SMA. This evidence concerns the gene INHBE and proximal spinal muscular atrophy.